[go: up one dir, main page]

Gignac, 2019 - Google Patents

Modeling human gene variants that affect WNT signalling in the chicken embryo

Gignac, 2019

View PDF
Document ID
4960453143297101156
Author
Gignac S
Publication year

External Links

Snippet

The study of rare genetic diseases provides valuable insights into human gene function. The chicken embryo was used as a model to investigate the role of WNT signaling in skeletogenesis and to elucidate the functional consequences of mutations in dominant …
Continue reading at open.library.ubc.ca (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Similar Documents

Publication Publication Date Title
Francis-West et al. Craniofacial development the tissue and molecular interactions that control development of the head
Schweitzer et al. Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments
Gignac et al. Robinow syndrome skeletal phenotypes caused by the WNT5AC83S variant are due to dominant interference with chondrogenesis
Sagnol et al. Epithelial Splicing Regulatory Protein 1 (ESRP1) is a new regulator of stomach smooth muscle development and plasticity
Gignac Modeling human gene variants that affect WNT signalling in the chicken embryo
Tophkhane Mutations in Frizzled2 and Dishevelled1 inhibit skeletogenesis and disturb WNT signaling during the craniofacial development in the chicken embryo
Bonaparte Skeletogenic studies in avian primary limb cultures shed new insights into the functions of syndromic Dishevelled-1 (DVL1) variants
Perez-Pomares et al. Wt1+/Itga4+ progenitors drive epicardial-derived cell expansion via non-canonical Wnt signalling
Parmar Elucidating the Role of Cyclooxygenase-2 in the Morphogenesis of Craniofacial Structures in Domestic Chick
Papaefthymiou Role of the Srf transcription factor in adult muscle stem cells
Saiz López Cell signaling and patterning in limb development: analysis in recombinant limbs and by cell grafting
Sohail Identifying Dlx Regulated Genes in the Chick Craniofacial Primordia
Sheikh-Hassani TBX5 Mechanism of Action in Skeletal Muscle Cell Proliferation and Differentiation
Rubio Nuclear VANGL2 Inhibits Mammary Differentiation
Wong The Roles of Irx3 and Irx5 in First Pharyngeal Arch Development
Kühl Wnt signaling in development
Goff Puzzle card
de Bettignies Wnt/Fz interactions in the developing central nervous system
WILLEMS CELLULAR AND MOLECULAR CONTROL OF SKELETON FORMATION IN FISH: INSIGHTS FROM OSTEOBLAST ABLATION AND FUNCTIONAL CHARACTERIZATION OF LRP5 AND SOST
McLean Notch activation induces an endothelial-to-mesenchymal transformation
Zhang Regulation of Skeletal Muscle Development and Differentiation by Ski
Treat The Role of NHERF1/EBP50 in WNT Signaling in the Epithelium
Wood MyoD+ Progenitors are Required for Skeletal Myogenesis and Proper Rib Development
Liu The role of Wnt signaling pathway in mammalian retinal development
Windner Segmentation genes and the development of skeletal muscle progenitors in zebrafish